Dutch Green Chemtech innovator Affix Labs has announced the successful closure of a significant funding round, co-led by investment firms VP Capital and Oost NL. This strategic financial injection is poised to accelerate the market rollout of its flagship product, Repeltec, and its proprietary water-based solubility technology. The investment comes at a crucial juncture as tightening European Union pesticide regulations create a strong demand for safer, more sustainable pest control solutions.
A Technological Breakthrough in Formulation
Affix Labs has developed a patented formulation method that overcomes a long-standing challenge in the chemical industry by dissolving oily, water-insoluble active ingredients into water-based systems. This core innovation is complemented by a controlled-release layer that ensures the product's efficacy for an extended period of up to twelve weeks. The resulting insect barrier is both powerful and safe, offering a compelling alternative to traditional chemical-heavy products on the market.
Meeting Market Demand with Repeltec
The company's flagship product, Repeltec, exemplifies this advanced technology, providing a long-lasting and effective insect barrier. Crucially, the product has been dermatologically tested and is formulated without any neurotoxic compounds, addressing growing consumer concerns about health and environmental safety. This focus on safety and efficacy makes it an ideal solution for households and commercial spaces seeking responsible pest management methods.
Navigating Europe's Evolving Regulatory Landscape
The timing of this expansion is critical, as EU rules governing chemical pesticides are becoming increasingly strict across the continent. Germany's 2025 self-service ban on a wide array of neurotoxic insecticides is a landmark measure that is prompting similar actions in other member states. Affix Labs is well-positioned to capitalize on this shift, already holding active substance authorizations in Germany, France, Austria, and Norway.
Fueling Expansion and Forging B2B Partnerships
With the new capital, Affix Labs is launching a multi-faceted commercial expansion, initially strengthening its presence in Germany, Austria, France, and Norway before targeting the UK and Poland. In a significant strategic move, the company is also launching a white-label B2B model called "Powered by Affix Labs." This program allows FMCG companies, hospitality operators, and pest control manufacturers to integrate the patented technology directly into their own product lines.
A Vision for a Pesticide-Reduced Future
The investment from VP Capital and Oost NL validates Affix Labs' mission to reduce global dependency on harmful pesticides. The company's approach combines green chemistry with practical, long-lasting applications to create a new standard in the pest control industry. By making its technology accessible through both consumer products and B2B partnerships, Affix Labs aims to drive systemic change toward safer alternatives.
This successful funding round provides Affix Labs with the resources to scale its operations and solidify its position as a leader in the green chemtech space. As regulatory pressures and consumer preferences continue to favor sustainable solutions, the company's innovative, neurotoxic-free technology is set to make a significant impact. The expansion across Europe represents a major step forward in its goal of delivering safer and more effective pest control globally.